Press "Enter" to skip to content

Amylyx drug helps slow ALS progression in mid-stage study

ALS, also known as Lou Gehrig’s disease, is a rare disorder that attacks nerve cells responsible for controlling voluntary muscles, and over 6,000 Americans are diagnosed with the disease every year, according to the ALS Association.

Original source: https://health.economictimes.indiatimes.com/news/pharma/amylyx-drug-helps-slow-als-progression-in-mid-stage-study/72863941?utm_source=RSS&utm_medium=ETRSS

Also Read:   Lupin gets 6 observations from USFDA for its Pithampur Unit-2